mango
Senior Member (Voting Rights)
BPS proponents David Gyll, Carl Sjöström and Henrik Vogt wrote a reply:Opinon piece in the journal of the Swedish Medical Association, by prof Jonas Bergquist and others.
Postinfektiösa tillstånd kräver kunskapsstyrning
https://lakartidningen.se/opinion/debatt/2022/09/postinfektiosa-tillstand-kraver-kunskapsstyrning/
Brett perspektiv ger precision vid postcovid
https://lakartidningen.se/opinion/debatt/2022/10/brett-perspektiv-ger-precision-vid-postcovid/
Google Translate, English ("Broad perspective provides precision in postcovid")
Auto-translate said:[...] It is perfectly possible to respect and value patients' symptoms and experiences, while maintaining a healthy scepticism about dubious pathophysiological theories. Postinfectious symptoms have a history of controversial diagnoses such as chronic Lyme disease and myalgic encephalomyelitis [5]. Long covid is a diagnosis created by patients on social media [6]. This highlights the necessary constructivist understanding of diagnoses.
Karin Johannisson writes in LT [7] that one aspect of every diagnosis is illness as a cultural construct [...]
Believing that genomics, proteomics or other "omics" can fully explain postcovid rests on an epistemological view in which real explanations of cause are seen as occurring primarily at the cellular level. The assumption that this is true of postcovid risks missing important, potentially modifiable, causal factors. In our experience, postcovid has very few similarities with cancer, but overlaps with stress syndromes, fatigue conditions and functional conditions. Patients are helped by interventions drawn from knowledge of this [12].
In order to understand postinfectious syndromes and help individuals, more research is needed that takes a holistic approach to psychological, sociological, anthropological and biological perspectives [13]. The biopsychosocial model can be a tool to achieve this [14].
Bergquist et al recently replied:
Replik: Författarna har missförstått vår avsikt
https://lakartidningen.se/opinion/debatt/2022/10/replik-forfattarna-har-missforstatt-var-avsikt/
Google Translate, English ("Reply: The authors have misunderstood our intention")
Auto-translate said:[...] Unexplained symptoms are not the same as inexplicable symptoms [5].
The risk of false findings decreases with time [6], so let's look forward and not backward. Pathophysiological theories about the genesis of postinfectious conditions [7, 8] can withstand the healthy scepticism called for by the authors [1, 9]. Globally, it is estimated that approximately 145 million people are affected by postcovid [10, 11]. The WHO urges us to take postcovid immediately and seriously [10, 13].
In Sweden, there are gaps in postcovid care [14], and we are concerned that the development of more evidence-based care is stagnating in a debate that questions the origin, existence and nature of the condition. Postcovid research is no longer about dubiously supported theories. The Litcovid database currently lists over 10,000 published scientific articles on postcovid [15].
Despite over 16,000 research articles on the Web of science, pathophysiological findings, diagnostic codes and criteria, and international guidelines for the related complex condition ME/CFS, commentators write that it is a controversial diagnosis [7, 16-19]. Instead of washing away this stigma, they refer to a criticized 1970 article that claimed that ME/CFS could be nothing more than "epidemic hysteria" [20, 21]. What is remarkable about the reference is that the conclusion of mass hysteria is based on the fact that post-infectious symptoms at the time of the 1955 outbreak mainly affected young women, reflecting an outdated view of human nature [...].
New research on postinfectious conditions at the cellular level can likewise inform us about genetics and prognosis and predict treatment effects. In addition, biomarkers should identify patients who do not suffer from postcovid but from other conditions. The knowledge includes the whole human being, hence also (obviously not only) human cells.